nach oben

Molecular Diagnosis & Therapy

Erschienen in:

01.10.2016 | Current Opinion

Genomic Testing in The Paediatric Population: Ethical Considerations in Light of Recent Policy Statements

verfasst von: Ainsley J. Newson, Lisa Schonstein

Erschienen in: Molecular Diagnosis & Therapy | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Genomic testing is rapidly becoming established in clinical practice and research. In this paper we consider the ethical issues arising in genomic testing in children, focusing on the clinical context. After describing how genomics can be said to depart from genetics in ethically relevant ways, we introduce two case studies involving ethical issues in paediatric genomic testing. We then summarise and critically engage with recent professional statements regarding genomic testing in children; notably the 2015 position statement from the American Society for Human Genetics. To provide a conceptual framework for these debates, we then synthesise recent bioethics literature regarding appropriate concepts to use when making decisions regarding children, and applying them to genomic testing. We recommend an approach to genomic testing in children that is child-focused and flexibly applied, driven by a core clinical question. Finally, we examine the role that age and emerging capacity should play in these debates.

We focus our discussion on the use of genomic testing in circumstances when a test is being considered to answer a clinical question relating to a child’s diagnosis or prognosis. We do not discuss single-gene genetic testing or pharmacogenomics; nor do we consider the use of genomic testing in ‘first-line’ newborn screening or its provision direct to consumers without clinical recommendation.

In this paper we use the term ‘children’ to mean any person under the age of 16. In Sect. 5 we consider the impact that a child’s developing autonomy and sense of self should have on decisions regarding genomic testing.

We interpret ‘genomic testing’ to include approaches such as whole genome sequencing, whole exome sequencing and panel testing; or other approaches that exploit massively parallel DNA sequencing techniques.

The ASHG and AAP/ACMG may reply to this by contending that their position statements are not ethically normative, merely directions for practice and research. However, they are written using language that could be interpreted as having normative intention, such as the use of ‘should’ and ‘must’. The statements also explicitly reference ethical issues.

It could be argued that acting in a family’s best interests could also be said to be an action in a child’s best interests too. We address this point later in the paper.

This level is explained further by Jonas, who takes a welfare-based account of interests; following legal philosopher Joel Feinberg. One description of an acceptable level of interest-fulfillment is one that meets minimal welfare considerations.

Alongside the scenarios we discuss, other situations may also arise in which a child who is capable of engaging in decision-making expresses an opinion regarding testing that diverges from that of her carers. Such a discussion is beyond the scope of this paper.

Ross LF, Saal HM, David KL, Anderson RR. American Academy of Pediatrics, American College of Medical Genetics and Genomics. Technical report: ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15(3):234–45.CrossRefPubMed

Dondorp WJ, de Wert GM. The ‘thousand-dollar genome’: an ethical exploration. Eur J Hum Genet. 2013;21(Suppl 1):S6–26.CrossRefPubMedPubMedCentral

Royal College of Pathologists Australia. Massively parallel sequencing implementation guidelines: ethical and legal issues. RCPA. 2015. http://www.rcpa.edu.au/Library/Practising-Pathology/RCPA-Genetic-Testing/MAPSIG/ELIssues. Accessed 15 May 2016.

Botkin J, Belmont J, Berg J, Berkman B, Bombard Y, Holm I, et al. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 2015;97(1):6–21.CrossRefPubMedPubMedCentral

Biesecker BB, Klein W, Lewis KL, Fisher TC, Wright MF, Biesecker LG, et al. How do research participants perceive “uncertainty” in genome sequencing? Genet Med. 2014;16(12):977–80.CrossRefPubMedPubMedCentral

Cooper GM. Parlez-vous VUS? Genome Res. 2015;25(10):1423–6.CrossRefPubMedPubMedCentral

American Society of Human Genetics, American College of Medical Genetics. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57(5):1233–41.

American Academy of Pediatrics, Committee on Bioethics, Committee on Genetics, American College of Medical Genetics, Genomics Social Ethical and Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Pediatrics. 2013;131(3):620–2.CrossRef

Wilfond B, Ross LF. From genetics to genomics: ethics, policy, and parental decision-making. J Pediatr Psychol. 2009;34(6):639–47.CrossRefPubMed

10.

Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565–74.CrossRefPubMedPubMedCentral

11.

American College of Medical Genetics and Genomics. ACMG practice guideline: incidental findings in clinical genomics: a clarification. In: A policy statement of the American College of Medical Genetics and Genomics. Bethesda. 2013. https://www.acmg.net/docs/Incidental_Findings_in_Clinical_genomics_A_Clarification.pdf. Accessed 24 Oct 2015.

12.

Hardart GE, Chung WK. Genetic testing of children for diseases that have onset in adulthood: the limits of family interests. Pediatrics. 2014;134(Suppl 2):S104–10.CrossRefPubMedPubMedCentral

13.

Feinberg J. The child’s right to an open future. In: Aiken W, LaFollette H, editors. Whose child? Children’s rights, parental authority, and state power. Totowa: Littlefield, Adams and Company; 1980. p. 124–53.

14.

Davies R, Ives J, Dunn M. A systematic review of empirical bioethics methodologies. BMC Med Ethics. 2015;16:15. doi:10.1186/s12910-015-0010-3.CrossRefPubMedPubMedCentral

15.

Edwards KT, Deans Z. Empirical ethics and the role of the professional ethicist in public policymaking. In: Ives J, Dunn M, Cribb A, editors. Interdisciplinary and empirical ethics: practical and theoretical perspectives. Cambridge: Cambridge University Press; 2016 (in press).

16.

Blustein J. Parents and children: the ethics of the family. New York: Oxford University Press; 1982.

17.

Carbone J. Legal applications of the “best interest of the child” standard: judicial rationalization or a measure of institutional competence? Pediatrics. 2014;134(Suppl 2):S111–20.CrossRefPubMed

18.

Ross LF. Predictive genetic testing of children and the role of the best interest standard. J Law Med Ethics. 2013;41(4):899–906.CrossRefPubMed

19.

Diekema DS. Parental refusals of medical treatment: the harm principle as threshold for state intervention. Theor Med Bioeth. 2004;25(4):243–64.CrossRefPubMed

20.

Birchley G. Harm is all you need? Best interests and disputes about parental decision-making. J Med Ethics. 2016;42(2):111–5.CrossRefPubMed

21.

Gillam L. The zone of parental discretion: an ethical tool for dealing with disagreement between parents and doctors about medical treatment for a child. Clin Ethics. 2016;11(1):1–8.CrossRef

22.

Clayton EW, McCullough LB, Biesecker LG, Joffe S, Ross LF, Wolf SM, et al. Addressing the ethical challenges in genetic testing and sequencing of children. Am J Bioethics. 2014;14(3):3–9. doi:10.1080/15265161.2013.879945.CrossRef

23.

Fenwick A. Are guidelines for genetic testing of children necessary? Fam Cancer. 2010;9(1):23–5. doi:10.1007/s10689-009-9278-0.CrossRefPubMed

24.

Haga SB, Terry SF. Ensuring the safe use of genomic medicine in children. Clin Pediatr. 2009;48(7):703–8.CrossRef

25.

May T, Zusevics KL, Strong KA. On the ethics of clinical whole genome sequencing of children. Pediatrics. 2013;132(2):207–9.CrossRefPubMed

26.

Jonas M. Assessing baselines for identifying harm: tricky cases and and childhood. Res Publica. 2015. doi:10.1007/s11158-015-9293-y.

Titel: Genomic Testing in The Paediatric Population: Ethical Considerations in Light of Recent Policy Statements
verfasst von: Ainsley J. Newson
Lisa Schonstein
Publikationsdatum: 01.10.2016
Verlag: Springer International Publishing
Erschienen in: Molecular Diagnosis & Therapy / Ausgabe 5/2016
Print ISSN: 1177-1062
Elektronische ISSN: 1179-2000
DOI: https://doi.org/10.1007/s40291-016-0210-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Genomic Testing in The Paediatric Population: Ethical Considerations in Light of Recent Policy Statements

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

Genetic Mutation Analysis of Parkinson’s Disease Patients Using Multigene Next-Generation Sequencing Panels

Liquid Biopsies in Oncology and the Current Regulatory Landscape

Pivotal MicroRNAs in Melanoma: A Mini-Review

The Future of Digital Polymerase Chain Reaction in Virology

Impacts of TNF-LTA SNPs/Haplotypes and Lifestyle Factors on Oral Carcinoma in an Indian Population

Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin